ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 487,800 shares, a decrease of 33.1% from the March 31st total of 729,300 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily volume of 520,900 shares, the short-interest ratio is currently 0.9 days.
ReShape Lifesciences Stock Down 4.6 %
RSLS stock traded down $0.01 on Friday, hitting $0.17. 318,579 shares of the company’s stock traded hands, compared to its average volume of 292,479. ReShape Lifesciences has a 1-year low of $0.14 and a 1-year high of $2.80. The stock has a fifty day moving average of $0.17 and a 200-day moving average of $0.22.
Institutional Investors Weigh In On ReShape Lifesciences
An institutional investor recently bought a new position in ReShape Lifesciences stock. Armistice Capital LLC bought a new position in ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 188,000 shares of the medical device company’s stock, valued at approximately $64,000. Armistice Capital LLC owned approximately 5.45% of ReShape Lifesciences as of its most recent SEC filing. 22.06% of the stock is owned by hedge funds and other institutional investors.
ReShape Lifesciences Company Profile
ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation.
Read More
- Five stocks we like better than ReShape Lifesciences
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 4/22 – 4/26
- P/E Ratio Calculation: How to Assess Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.
